"The Future of ALS Clinical Trials…"

Welcome to Connecting ALS. On this episode we talk to Dr. Merit Cudkowicz about the impact of COVID-19 on conducting clinical trials.

Show Notes

On this week’s episode, Mike and Jeremy talk to Dr. Merit Cudkowicz, chief of neurology at Massachusetts General Hospital and director of the Sean M. Healey & AMG Center for ALS, about the impact of COVID-19 on conducting clinical trials. Dr. Cudkowicz also provides an update on the Healey Platform Trial and potential long-term changes to trial design.

To learn more about Dr. Cudkowicz, go to https://www.massgeneral.org/doctors/16904/merit-cudkowicz

Read all about the Healey Platform Trial at https://alsadotorg.wordpress.com/2020/01/17/in-case-you-missed-it-the-als-association-invests-3-million-in-first-ever-als-platform-trial-to-speed-up-clinical-trial-process/

This episode was produced by Garrett Tiedemann and is brought to you by The ALS Association’s national office and the Association’s Minnesota/North Dakota/South Dakota Chapter. 

What is Connecting ALS?

Connecting ALS is a weekly podcast produced by The ALS Association in partnership with CitizenRacecar. We aim to discuss research and technology developments, highlight advocacy efforts, and share the personal stories woven through the community.